Literature DB >> 26783342

The Length Distribution of Class I-Restricted T Cell Epitopes Is Determined by Both Peptide Supply and MHC Allele-Specific Binding Preference.

Thomas Trolle1, Curtis P McMurtrey2, John Sidney3, Wilfried Bardet2, Sean C Osborn2, Thomas Kaever3, Alessandro Sette3, William H Hildebrand2, Morten Nielsen4, Bjoern Peters5.   

Abstract

HLA class I-binding predictions are widely used to identify candidate peptide targets of human CD8(+) T cell responses. Many such approaches focus exclusively on a limited range of peptide lengths, typically 9 aa and sometimes 9-10 aa, despite multiple examples of dominant epitopes of other lengths. In this study, we examined whether epitope predictions can be improved by incorporating the natural length distribution of HLA class I ligands. We found that, although different HLA alleles have diverse length-binding preferences, the length profiles of ligands that are naturally presented by these alleles are much more homogeneous. We hypothesized that this is due to a defined length profile of peptides available for HLA binding in the endoplasmic reticulum. Based on this, we created a model of HLA allele-specific ligand length profiles and demonstrate how this model, in combination with HLA-binding predictions, greatly improves comprehensive identification of CD8(+) T cell epitopes.
Copyright © 2016 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26783342      PMCID: PMC4744552          DOI: 10.4049/jimmunol.1501721

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  46 in total

1.  Binding of longer peptides to the H-2Kb heterodimer is restricted to peptides extended at their C terminus: refinement of the inherent MHC class I peptide binding criteria.

Authors:  H Hörig; A C Young; N J Papadopoulos; T P DiLorenzo; S G Nathenson
Journal:  J Immunol       Date:  1999-10-15       Impact factor: 5.422

2.  The sizes of peptides generated from protein by mammalian 26 and 20 S proteasomes. Implications for understanding the degradative mechanism and antigen presentation.

Authors:  A F Kisselev; T N Akopian; K M Woo; A L Goldberg
Journal:  J Biol Chem       Date:  1999-02-05       Impact factor: 5.157

3.  Two complementary methods for predicting peptides binding major histocompatibility complex molecules.

Authors:  K Gulukota; J Sidney; A Sette; C DeLisi
Journal:  J Mol Biol       Date:  1997-04-18       Impact factor: 5.469

4.  Automated benchmarking of peptide-MHC class I binding predictions.

Authors:  Thomas Trolle; Imir G Metushi; Jason A Greenbaum; Yohan Kim; John Sidney; Ole Lund; Alessandro Sette; Bjoern Peters; Morten Nielsen
Journal:  Bioinformatics       Date:  2015-02-25       Impact factor: 6.937

5.  Three-dimensional structure of a peptide extending from one end of a class I MHC binding site.

Authors:  E J Collins; D N Garboczi; D C Wiley
Journal:  Nature       Date:  1994-10-13       Impact factor: 49.962

6.  Naturally processed peptides longer than nine amino acid residues bind to the class I MHC molecule HLA-A2.1 with high affinity and in different conformations.

Authors:  Y Chen; J Sidney; S Southwood; A L Cox; K Sakaguchi; R A Henderson; E Appella; D F Hunt; A Sette; V H Engelhard
Journal:  J Immunol       Date:  1994-03-15       Impact factor: 5.422

7.  Existence of a molecular ruler in proteasomes suggested by analysis of degradation products.

Authors:  T Wenzel; C Eckerskorn; F Lottspeich; W Baumeister
Journal:  FEBS Lett       Date:  1994-08-01       Impact factor: 4.124

8.  High resolution structures of highly bulged viral epitopes bound to major histocompatibility complex class I. Implications for T-cell receptor engagement and T-cell immunodominance.

Authors:  Fleur E Tynan; Natalie A Borg; John J Miles; Travis Beddoe; Diah El-Hassen; Sharon L Silins; Wendy J M van Zuylen; Anthony W Purcell; Lars Kjer-Nielsen; James McCluskey; Scott R Burrows; Jamie Rossjohn
Journal:  J Biol Chem       Date:  2005-04-22       Impact factor: 5.157

9.  T cell control of primary and latent cytomegalovirus infections in healthy subjects.

Authors:  Anna K Lidehall; Fredrik Sund; Tobias Lundberg; Britt-Marie Eriksson; Thomas H Tötterman; Olle Korsgren
Journal:  J Clin Immunol       Date:  2005-09       Impact factor: 8.317

10.  Peptide length and sequence specificity of the mouse TAP1/TAP2 translocator.

Authors:  T N Schumacher; D V Kantesaria; M T Heemels; P G Ashton-Rickardt; J C Shepherd; K Fruh; Y Yang; P A Peterson; S Tonegawa; H L Ploegh
Journal:  J Exp Med       Date:  1994-02-01       Impact factor: 14.307

View more
  65 in total

Review 1.  T-Cell Receptor-Based Immunotherapy for Hematologic Malignancies.

Authors:  Melinda A Biernacki; Michelle Brault; Marie Bleakley
Journal:  Cancer J       Date:  2019 May/Jun       Impact factor: 3.360

2.  Human Leukocyte Antigen F Presents Peptides and Regulates Immunity through Interactions with NK Cell Receptors.

Authors:  Charles L Dulberger; Curtis P McMurtrey; Angelique Hölzemer; Karlynn E Neu; Victor Liu; Adriana M Steinbach; Wilfredo F Garcia-Beltran; Michael Sulak; Bana Jabri; Vincent J Lynch; Marcus Altfeld; William H Hildebrand; Erin J Adams
Journal:  Immunity       Date:  2017-06-20       Impact factor: 31.745

3.  The Activation State of CD4 T Cells Alters Cellular Peptidase Activities, HIV Antigen Processing, and MHC Class I Presentation in a Sequence-Dependent Manner.

Authors:  Julie Boucau; Julien Madouasse; Georgio Kourjian; Christopher S Carlin; Daniel Wambua; Matthew J Berberich; Sylvie Le Gall
Journal:  J Immunol       Date:  2019-04-01       Impact factor: 5.422

4.  Mass spectrometry-based identification of MHC-bound peptides for immunopeptidomics.

Authors:  Anthony W Purcell; Sri H Ramarathinam; Nicola Ternette
Journal:  Nat Protoc       Date:  2019-05-15       Impact factor: 13.491

Review 5.  T cell receptor repertoire usage in cancer as a surrogate marker for immune responses.

Authors:  David Schrama; Cathrin Ritter; Jürgen C Becker
Journal:  Semin Immunopathol       Date:  2017-01-10       Impact factor: 9.623

6.  A Glimpse of the Peptide Profile Presentation by Xenopus laevis MHC Class I: Crystal Structure of pXela-UAA Reveals a Distinct Peptide-Binding Groove.

Authors:  Lizhen Ma; Nianzhi Zhang; Zehui Qu; Ruiying Liang; Lijie Zhang; Bing Zhang; Geng Meng; Johannes M Dijkstra; Shen Li; Max Chun Xia
Journal:  J Immunol       Date:  2019-11-27       Impact factor: 5.422

7.  NetMHCpan-4.0: Improved Peptide-MHC Class I Interaction Predictions Integrating Eluted Ligand and Peptide Binding Affinity Data.

Authors:  Vanessa Jurtz; Sinu Paul; Massimo Andreatta; Paolo Marcatili; Bjoern Peters; Morten Nielsen
Journal:  J Immunol       Date:  2017-10-04       Impact factor: 5.422

8.  In silico and cell-based analyses reveal strong divergence between prediction and observation of T-cell-recognized tumor antigen T-cell epitopes.

Authors:  Julien Schmidt; Philippe Guillaume; Danijel Dojcinovic; Julia Karbach; George Coukos; Immanuel Luescher
Journal:  J Biol Chem       Date:  2017-05-23       Impact factor: 5.157

9.  Modeling Sequence-Dependent Peptide Fluctuations in Immunologic Recognition.

Authors:  Cory M Ayres; Timothy P Riley; Steven A Corcelli; Brian M Baker
Journal:  J Chem Inf Model       Date:  2017-07-25       Impact factor: 4.956

10.  Mass Spectrometry Profiling of HLA-Associated Peptidomes in Mono-allelic Cells Enables More Accurate Epitope Prediction.

Authors:  Jennifer G Abelin; Derin B Keskin; Siranush Sarkizova; Christina R Hartigan; Wandi Zhang; John Sidney; Jonathan Stevens; William Lane; Guang Lan Zhang; Thomas M Eisenhaure; Karl R Clauser; Nir Hacohen; Michael S Rooney; Steven A Carr; Catherine J Wu
Journal:  Immunity       Date:  2017-02-21       Impact factor: 31.745

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.